Now approved

ULTOMIRIS is the first and only long-acting medication approved by the FDA, dosed every 8 weeks after the loading dose, to treat adults with paroxysmal nocturnal hemoglobinuria (PNH).

Learn more in the Press Release

For patients:
Are you ready to start or switch?

OneSource™ is here to help. OneSource is a personalized patient support program staffed by Alexion Nurse Case Managers, all of whom are registered nurses with extensive clinical experience—giving you the support you need when starting a new treatment.

Join OneSource™

Download the OneSource enrollment form

Need more information before starting ULTOMIRIS?

Download our patient brochure, which will give you valuable information about this long-acting treatment, including how it works, how you take it, and what to expect.

Patient brochure

Switching from eculizumab

For healthcare professionals:
Support to help start or switch patients

Download J-code guide

Get the information you need to start or switch your patient and get detailed instructions on how to administer ULTOMIRIS.

Explore the ULTOMIRIS REMS program

Dosing and administration guide

J-code guide

Sign up to learn more about ULTOMIRIS.

Please select one:

ALL FIELDS REQUIRED

Thank you for subscribing

We have successfully received your subscription request.
You’ll see one of our emails arriving in your inbox sometime soon.